JP2021533801A5 - - Google Patents
Info
- Publication number
- JP2021533801A5 JP2021533801A5 JP2021509904A JP2021509904A JP2021533801A5 JP 2021533801 A5 JP2021533801 A5 JP 2021533801A5 JP 2021509904 A JP2021509904 A JP 2021509904A JP 2021509904 A JP2021509904 A JP 2021509904A JP 2021533801 A5 JP2021533801 A5 JP 2021533801A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- recombinant nucleic
- vector
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810968173.0 | 2018-08-23 | ||
| CN201810968173.0A CN110857440B (zh) | 2018-08-23 | 2018-08-23 | 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用 |
| PCT/CN2019/102352 WO2020038473A1 (zh) | 2018-08-23 | 2019-08-23 | 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533801A JP2021533801A (ja) | 2021-12-09 |
| JP2021533801A5 true JP2021533801A5 (enExample) | 2022-08-31 |
| JP7285022B2 JP7285022B2 (ja) | 2023-06-01 |
Family
ID=69592310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021509904A Active JP7285022B2 (ja) | 2018-08-23 | 2019-08-23 | 組換えヒトＩＩ型ミトコンドリアダイニン様ＧＴＰａｓｅの遺伝子配列及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11459584B2 (enExample) |
| EP (1) | EP3851535A4 (enExample) |
| JP (1) | JP7285022B2 (enExample) |
| KR (1) | KR102612148B1 (enExample) |
| CN (1) | CN110857440B (enExample) |
| AU (1) | AU2019323501B2 (enExample) |
| BR (1) | BR112021002566A2 (enExample) |
| CA (1) | CA3110153A1 (enExample) |
| MX (1) | MX2021002135A (enExample) |
| SG (1) | SG11202101236WA (enExample) |
| WO (1) | WO2020038473A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110857440B (zh) | 2018-08-23 | 2021-02-19 | 武汉纽福斯生物科技有限公司 | 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用 |
| CN111849998A (zh) * | 2020-07-29 | 2020-10-30 | 武汉纽福斯生物科技有限公司 | 编码人卵黄状黄斑病蛋白1的核酸分子及其应用 |
| CN117904156A (zh) * | 2022-10-17 | 2024-04-19 | 武汉纽福斯生物科技有限公司 | 人线粒体动力蛋白样gtp酶及应用 |
| WO2024226729A2 (en) * | 2023-04-26 | 2024-10-31 | Astellas Gene Therapies, Inc. | Compositions and methods for opa1 gene therapy |
| CN117304293B (zh) * | 2023-10-07 | 2025-08-08 | 浙江大学 | 一种鸡opa1抗原决定簇及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| AU7906691A (en) | 1990-05-23 | 1991-12-10 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Adeno-associated virus (aav)-based eucaryotic vectors |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6989264B2 (en) | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| EP2369002A1 (en) | 1999-08-09 | 2011-09-28 | Targeted Genetics Corporation | Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| WO2006073496A2 (en) | 2004-07-30 | 2006-07-13 | Targeted Genetics Corporation | Recombinant aav based vaccine methods |
| PT1880008E (pt) * | 2005-05-03 | 2015-08-27 | Inserm Inst Nat De La Santé Et De La Rech Médicale | Expressão de proteína mitocondrial através de uma abordagem alotópica melhorada |
| EP2030021B1 (en) * | 2006-05-18 | 2012-11-21 | Andreas Reichert | Method for diagnosing mitochondrial dysfunction |
| CN102634527B (zh) * | 2012-04-11 | 2013-11-06 | 华中科技大学同济医学院附属同济医院 | 重组人nadh脱氢酶亚单位4基因及其表达载体构建方法 |
| JP2015527889A (ja) * | 2012-07-25 | 2015-09-24 | ザ ブロード インスティテュート， インコーポレイテッド | 誘導可能なｄｎａ結合タンパク質およびゲノム撹乱ツール、ならびにそれらの適用 |
| TW201514200A (zh) * | 2013-04-03 | 2015-04-16 | Aliophtha Ag | 用於治療由ｏｐａ１單倍體不足所造成的疾病之人工轉錄因子 |
| CN104450747B (zh) * | 2014-09-23 | 2018-02-09 | 武汉纽福斯生物科技有限公司 | 用于治疗Leber遗传性视神经病变的重组腺相关病毒‑NADH脱氢酶亚单位4基因全长以及药剂 |
| US20190275168A1 (en) * | 2015-04-30 | 2019-09-12 | The Trustees Of Columbia University In The City Of New York | Gene therapy for autosomal dominant diseases |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
| WO2018102672A1 (en) * | 2016-12-04 | 2018-06-07 | Alavi Khorassani Moghadam Marcel Victor | Methods for treating diseases related to mitochondrial stress |
| CN110392582A (zh) * | 2017-02-08 | 2019-10-29 | 弗里德里克·米谢尔生物医学研究所 | 用于使基因在视网膜神经节细胞中特异性表达的启动子SynP88 |
| CN111068071A (zh) * | 2018-10-22 | 2020-04-28 | 武汉纽福斯生物科技有限公司 | 基因治疗Leber遗传学视神经病变 |
| CN110857440B (zh) | 2018-08-23 | 2021-02-19 | 武汉纽福斯生物科技有限公司 | 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用 |
-
2018
- 2018-08-23 CN CN201810968173.0A patent/CN110857440B/zh active Active
-
2019
- 2019-08-23 CA CA3110153A patent/CA3110153A1/en active Pending
- 2019-08-23 EP EP19851390.5A patent/EP3851535A4/en not_active Withdrawn
- 2019-08-23 WO PCT/CN2019/102352 patent/WO2020038473A1/zh not_active Ceased
- 2019-08-23 KR KR1020217008407A patent/KR102612148B1/ko active Active
- 2019-08-23 BR BR112021002566-9A patent/BR112021002566A2/pt not_active IP Right Cessation
- 2019-08-23 JP JP2021509904A patent/JP7285022B2/ja active Active
- 2019-08-23 MX MX2021002135A patent/MX2021002135A/es unknown
- 2019-08-23 SG SG11202101236WA patent/SG11202101236WA/en unknown
- 2019-08-23 AU AU2019323501A patent/AU2019323501B2/en active Active
-
2021
- 2021-02-23 US US17/182,903 patent/US11459584B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7592332B2 (ja) | 横隔膜特異的核酸調節エレメントならびにその方法および使用 | |
| JP7577291B2 (ja) | Ａａｖカプシド設計 | |
| RU2738421C2 (ru) | Варианты рекомбинантных aav и их применения | |
| JP2026027271A5 (enExample) | ||
| CN112040988A (zh) | 修饰的aav衣壳多肽用于治疗肌肉疾病 | |
| US20200316221A1 (en) | Aav capsid designs | |
| TW201629225A (zh) | 第九因子基因療法 | |
| CN116440292A (zh) | Danon病和其它自噬障碍的治疗方法 | |
| JP2022524434A (ja) | Ｆｖｉｉｉ治療薬を発現するための非ウイルス性ｄｎａベクターおよびその使用 | |
| CN113195719A (zh) | 用于增加蛋白质表达和/或治疗单倍剂量不足症的方法及组合物 | |
| KR20250105716A (ko) | 간에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법 | |
| JP2019524090A5 (enExample) | ||
| CN111876432A (zh) | 一组肝靶向新型腺相关病毒的获得及其应用 | |
| JP2024527742A5 (enExample) | ||
| US20200024323A1 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
| WO2023202469A1 (zh) | 一种用于遗传性凝血因子缺乏病治疗的核酸构建体及其用途 | |
| ES2773305T3 (es) | Composición para la prevención o tratamiento de la esclerosis lateral amiotrófica que utiliza dos o más isoformas del factor de crecimiento de hepatocitos | |
| JP2024529170A (ja) | 治療薬の逆行性冠状静脈又は洞投与 | |
| JP2024502044A (ja) | センス・サプレッサートランスファーｒｎａ組成物ならびに関連する用途及び機能 | |
| US20260124322A1 (en) | Atp7b gene therapy | |
| JP2025523952A (ja) | 筋肉特異的調節カセット | |
| TW202337476A (zh) | 用於與肌肉萎縮蛋白有關之心肌病之基因療法組合物及治療 | |
| JP2024528997A (ja) | 放射線誘発性唾液機能低下を予防するためのａｑｐ１遺伝子療法 | |
| JP2024502257A (ja) | 心筋細胞由来核酸調節エレメント並びにその方法及び使用 | |
| JP7860176B2 (ja) | 変異ａａｖ、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法 |